RMA
MRK icon

Roffman Miller Associates’s Merck MRK Stock Holding History

Roffman Miller Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4M Buy
228,418
+264
+0.1% +$30.9K 1.53% 24
2026
Q1 		$27.4M Sell
228,154
-3,369
-1% -$389K 1.58% 25
2025
Q4 		$24.4M Buy
231,523
+19,717
+9% +$1.85M 1.33% 27
2025
Q3 		$17.8M Buy
211,806
+6,581
+3% +$542K 1% 36
2025
Q2 		$16.2M Buy
205,225
+5,226
+3% +$415K 0.97% 40
2025
Q1 		$18M Buy
199,999
+5,792
+3% +$541K 1.13% 38
2024
Q4 		$19.3M Sell
194,207
-34,526
-15% -$3.56M 1.19% 32
2024
Q3 		$26M Sell
228,733
-24,939
-10% -$2.96M 1.59% 26
2024
Q2 		$31.4M Buy
253,672
+3,735
+1% +$481K 2.07% 21
2024
Q1 		$33M Sell
249,937
-1,412
-0.6% -$174K 2.21% 19
2023
Q4 		$27.4M Buy
251,349
+12,364
+5% +$1.28M 1.96% 22
2023
Q3 		$24.6M Buy
238,985
+6,273
+3% +$676K 1.95% 23
2023
Q2 		$26.9M Sell
232,712
-7,093
-3% -$805K 2.02% 21
2023
Q1 		$25.5M Buy
239,805
+1,282
+0.5% +$138K 2.03% 21
2022
Q4 		$26.5M Buy
238,523
+3,964
+2% +$405K 2.18% 19
2022
Q3 		$20.2M Buy
234,559
+2,880
+1% +$257K 1.84% 25
2022
Q2 		$21.1M Sell
231,679
-10,263
-4% -$910K 1.83% 26
2022
Q1 		$19.9M Buy
241,942
+172
+0.1% +$13.6K 1.48% 29
2021
Q4 		$18.5M Buy
241,770
+9,962
+4% +$793K 1.25% 33
2021
Q3 		$17.4M Sell
231,808
-62,656
-21% -$4.77M 1.29% 32
2021
Q2 		$17.2M Sell
294,464
-2,686
-0.9% -$200K 1.3% 32
2021
Q1 		$16.3M Buy
297,150
+35,493
+14% +$2.62M 1.35% 31
2020
Q4 		$14.6M Buy
261,657
+95,261
+57% +$7.29M 1.26% 32
2020
Q3 		$13.2M Buy
166,396
+20,802
+14% +$1.63M 1.27% 33
2020
Q2 		$10.7M Buy
145,594
+24,542
+20% +$1.85M 1.07% 35
2020
Q1 		$8.89M Buy
121,052
+30,846
+34% +$2.42M 1.11% 35
2019
Q4 		$7.83M Buy
90,206
+41,723
+86% +$3.43M 0.78% 36
2019
Q3 		$3.89M Buy
48,483
+22,656
+88% +$1.82M 0.41% 41
2019
Q2 		$2.07M Buy
25,827
+2,125
+9% +$163K 0.22% 46
2019
Q1 		$1.87M Buy
+23,702
New +$1.77M 0.21% 47
2018
Q4 		– Sell
-22,554
Closed -$1.53M – 78
2018
Q3 		$1.53M Buy
22,554
+5,029
+29% +$320K 0.17% 50
2018
Q2 		$1.01M Buy
17,525
+2,074
+13% +$117K 0.12% 51
2018
Q1 		$803K Sell
15,451
-1,158
-7% -$62.5K 0.1% 54
2017
Q4 		$892K Buy
16,609
+133
+0.8% +$7.37K 0.11% 53
2017
Q3 		$1.01M Sell
16,476
-1,357
-8% -$82.3K 0.13% 54
2017
Q2 		$1.09M Buy
17,833
+509
+3% +$31K 0.15% 51
2017
Q1 		$1.05M Buy
17,324
+1,320
+8% +$80.1K 0.15% 51
2016
Q4 		$899K Buy
+16,004
New +$937K 0.14% 52

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Roffman Miller Associates's MRK Position: Q2 2026 in Review

Roffman Miller Associates increased its Merck (MRK) stake by 0.12% in Q2 2026, buying an estimated $30.9K and bringing the position to 228,418 shares worth $29.4M. The position accounts for 1.53% of the portfolio, ranked #24.

Roffman Miller Associates first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $33M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Roffman Miller Associates held 228,418 shares of Merck worth $29.4M as of Q2 2026.
  • Roffman Miller Associates bought 264 Merck shares in Q2 2026, an estimated $30.9K.
  • Merck made up 1.53% of Roffman Miller Associates's portfolio in Q2 2026, its #24 holding.
  • Roffman Miller Associates first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
  • Roffman Miller Associates's Merck position peaked at $33M in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.